Evidence map›Paper›PMID 39669248›Full record

ArticleGenetics in medicine open2023

A multicenter cross-sectional study in infants with congenital heart defects demonstrates high diagnostic yield of genetic testing but variable evaluation practices.

Matthew D Durbin, Lindsey R Helvaty, Ming Li, William Border, Sara Fitzgerald-Butt, Vidu Garg, Gabrielle C Geddes, Benjamin M Helm, Seema R Lalani, Kim L McBride and 6 more

Abstract read
In one paragraph

Article in Genetics in medicine open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Genomic testing and molecular diagnosis among infants with congenital heart disease in the neonatal intensive care unit.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Observational
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Matthew D DurbinIndiana University School of Medicine, Indianapolis, IN.
Lindsey R HelvatyIndiana University School of Medicine, Indianapolis, IN.
Ming LiIndiana University School of Medicine, Indianapolis, IN.
William BorderEmory University School of Medicine, Atlanta, GA.
Sara Fitzgerald-ButtIndiana University School of Medicine, Indianapolis, IN.
Vidu GargCenter for Cardiovascular Research and Heart Center and Division of Genetic and Genomic Medicine at Nationwide Children's Hospital, and Department of Pediatrics, Ohio State University, Columbus, OH.
Gabrielle C GeddesIndiana University School of Medicine, Indianapolis, IN.
Benjamin M HelmIndiana University School of Medicine, Indianapolis, IN.
Seema R LalaniBaylor College of Medicine, Houston, TX.
Kim L McBrideCenter for Cardiovascular Research and Heart Center and Division of Genetic and Genomic Medicine at Nationwide Children's Hospital, and Department of Pediatrics, Ohio State University, Columbus, OH.
Alexis McEntireIndiana University School of Medicine, Indianapolis, IN.
Dana K MitchellIndiana University School of Medicine, Indianapolis, IN.
Chaya N MuraliBaylor College of Medicine, Houston, TX.
Stephanie B WechslerEmory University School of Medicine, Atlanta, GA.
Benjamin J LandisIndiana University School of Medicine, Indianapolis, IN.
Stephanie M WareIndiana University School of Medicine, Indianapolis, IN.

Funding

Transcriptional regulation of cardiac morphogenesisP01HL134599 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI MICHAEL RUBART-VAN DER LOHE · 2017 to 2026
$25.7M
Investigating the role of mitochondria in thoracic aortic aneurysm pathogenesisK23HL141667 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI LANDIS, BENJAMIN JOHN · 2019 to 2023
$810k
"SHROOM3 is a Novel Cause of Congenital Heart Disease"K08HL148508 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI DURBIN, MATTHEW D. · 2020 to 2024
$776k
NHLBI NIH HHS K08 HL148508NHLBI NIH HHS K23 HL141667NHLBI NIH HHS P01 HL134599
6 · The paper itself

Abstract

Purpose: For patients with congenital heart disease (CHD), the most common birth defect, genetic evaluation is not universally accepted, and current practices are anecdotal. Here, we analyzed genetic evaluation practices across centers, determined diagnostic yield of testing, and identified phenotypic features associated with abnormal results. Methods: This is a multicenter cross-sectional study of 5 large children's hospitals, including 2899 children ≤14 months undergoing surgical repair for CHD from 2013 to 2016, followed by multivariate logistics regression analysis. Results: Genetic testing occurred in 1607 of 2899 patients (55%). Testing rates differed highly between institutions (42%-78%, Conclusion: Genetics evaluation in CHD is diagnostically important but underused and highly variable, with high diagnostic rates across patient types, including in infants with presumed isolated CHD. These findings support recommendations for comprehensive testing and standardization of care.

Indexed as

Cardiovascular geneticsCongenital heart diseaseGenetic testing

Identifiers

PMID39669248
PMCPMC11613605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.